3,276 results on '"*LICHEN sclerosus et atrophicus"'
Search Results
2. Laser vs Clobetasol for Lichen Sclerosus
- Author
-
Clemens Tempfer, Principal Investigator
- Published
- 2024
3. StrataMGT for the Treatment of Vulvar Lichen Sclerosus
- Author
-
Stratpharma AG
- Published
- 2024
4. Extragenital lichen sclerosus et atrophicus-morphea overlap as an initial presentation of genital lichen sclerosus
- Author
-
Gordon, Emily R, Adeuyan, Oluwaseyi, Fahmy, Lauren M, Schreidah, Celine M, Trager, Megan H, Lapolla, Brigit A, Husain, Sameera, and Geskin, Larisa J
- Subjects
extragenital ,lichen sclerosus et atrophicus ,morphea ,overlap ,temporal - Abstract
Lichen sclerosus et atrophicus (LSA) is a chronic inflammatory disorder, most often characterized by atrophic skin plaques located on female genitalia. Infrequently, LSA may present extragenitally; however, much is unknown about the temporal relationship between genital and extragenital LSA. Morphea, also known as localized scleroderma, is a rare inflammatory skin condition characterized by sclerotic plaques. Investigators debate whether LSA and morphea exist on the same spectrum of disease, with LSA representing a superficial variant of morphea involving genitalia, or if they are distinct but coincidental entities. Although researchers have described LSA and morphea occurring in different locations on the same patient, few reports describe LSA and morphea occurring in the same lesion and in the inguinal folds. Herein, we report a case of a 62-year-old woman with extragenital LSA-morphea overlap in the inguinal folds, who three months later developed genital LSA. Extragenital LSA-morphea in the same plaque, with no signs of genital lesions on initial exam, with later development of genital LSA, is especially uncommon. The temporal progression of extragenital LSA-morphea overlap to genital LSA over a three-month period is an important contribution to the literature, as the temporal relationship between extragenital and genital LSA is not previously discussed.
- Published
- 2024
5. A Comparative Study on the Efficacy of AI Temperature-controlled Radiofrequency Technology and Electrical Stimulation in the Treatment of Vulvar Leukoplakia
- Published
- 2024
6. VALOR: Vaginal Atrophy & Long-term Observation of Recovery (VALOR)
- Published
- 2024
7. A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Lichen Sclerosus
- Published
- 2024
8. Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus
- Author
-
Prof. Dr. Volker Viereck, Head of Urogynecology
- Published
- 2024
9. Lasers in Gynecology.
- Author
-
Iglesia, Cheryl B., Choi, Jennie Eunsook, and Tadir, Yona
- Subjects
- *
PHOTOBIOMODULATION therapy , *LICHEN sclerosus et atrophicus , *LASER therapy , *URINARY incontinence , *PELVIC pain , *GENITOURINARY diseases - Abstract
The first published reports on the use of laser for cervical pathology date back to 1973. Technical advancements in flexible and rigid laser fibers revolutionized video laser laparoscopy in the 1990s. Fractionated lasers have been used to treat vulvovaginal symptoms associated with genitourinary syndrome of menopause, lichen sclerosus, and urinary incontinence. Review of available data suggests that fractionated lasers can improve both subjective and objective signs of vaginal atrophy and lichen sclerosus, but the evidence is weak because most of the trials are underpowered, are at risk for bias, and lack long-term follow-up. There is no strong evidence to support fractionated laser therapy for urinary incontinence or low-level laser therapy for chronic pelvic pain. Although short-term, single-arm trials suggest benefit of fractionated laser therapy for genitourinary syndrome of menopause, lichen sclerosus, and urinary incontinence, additional adequately powered, prospective, randomized, and longer-term comparative trials are needed before lasers can be recommended for these specific conditions. The purpose of this Clinical Expert Series is to review basic laser biophysics and the mechanism of action for modern fractionated lasers as relevant to the gynecologist. We also summarize safety and effectiveness data for lasers used for some of the most commonly studied gynecologic conditions: the vulvovaginal atrophy component of genitourinary syndrome of menopause, lichen sclerosus, and urinary incontinence. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Clinical outcomes with utilization of high-potency topical steroids in patients with lichen sclerosus-associated vulvar cancer.
- Author
-
Vue, Nujsaubnusi C., Sassani, Jessica, Prairie, Beth, Yin, Yue, Krivak, Thomas C., Crafton, Sarah, Morse, Christopher, Nakayama, John, Wield, Alyssa, Horne, Zachary D., and Miller, Eirwen M.
- Subjects
- *
VULVAR cancer , *PROPORTIONAL hazards models , *SQUAMOUS cell carcinoma , *LICHEN sclerosus et atrophicus , *CANCER relapse , *TREATMENT effectiveness - Abstract
To evaluate the impact of high-potency topical steroid use on risk of recurrence of lichen sclerosus-associated vulvar cancer. This is a retrospective cohort study evaluating patients with lichen sclerosus (LS)- associated vulvar squamous cell cancer (VSCC). Demographic and clinical outcome data were compared between two comparison groups: patients who received steroids, mainly clobetasol, and patients who did not receive steroids following treatment of LS-related vulvar cancer. Categorical variables were compared using Fisher's exact test or chi-square test. Continuous variables were compared using a two-sided student's t-test. Time to recurrence (TTR) and overall survival (OS) were analyzed using Kaplan-Meier survival plot and compared using Mantel-Cox log rank test. Cox proportional hazard regression models were conducted to generate hazard ratios for both TTR and OS. A p value of <0.05 was considered statistically significant. A total of 49 patients were included, with 36 patients receiving steroid treatment and 13 patients in the expectant management group. The median age of diagnosis was 68. The average BMI was 31.7 +/− 7.0. The median length of follow up was 41 months. The majority of patients were diagnosed with stage I VSCC. There was no difference in demographics or oncologic management of vulvar cancer between the two cohorts. Overall recurrence was decreased among patients who received steroid treatment when compared to patients who did not, 12 patients (33.3%) versus 9 patients (69.2%) respectively (p = 0.048). High-potency topical steroid use following treatment of lichen sclerosus-associated vulvar squamous cell carcinoma is associated with decreased risk of recurrence and prolonged median time to recurrence. • Lichen sclerosus - associated vulvar cancer carries a worse prognosis when compared with HPV- associated vulvar cancer. • Topical steroids represent standard of care therapy for lichen sclerosus but its impact on vulvar cancer risk is unknown. • High-potency topical steroids may reduce risk of recurrence and prolong recurrence free survival in LS-associated VSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Beyond vulvodynia: from a correct diagnosis to a multidisciplinary care program. A referral center experience.
- Author
-
Boero, Veronica, Cetera, Giulia Emily, Caia, Carlotta, Merli, Camilla Erminia Maria, Gramegna, Giada, Pesce, Elisa, Barbara, Giussy, Ermelinda, Monti, and Vercellini, Paolo
- Subjects
- *
VULVODYNIA , *VULVAR diseases , *GENITALIA infections , *DIAGNOSIS , *LICHEN sclerosus et atrophicus , *DIFFERENTIAL diagnosis , *CHRONIC pain - Abstract
Background: Vulvodynia is a chronic pain condition without an identifiable cause. As such, it is a diagnosis of exclusion, and all other causes of vulvar pain should be excluded. Although a standard treatment for vulvodynia has not been established yet, multidisciplinary care programs appear to be effective. Puropose: The aim of this retrospective monocentric study was to analyze the prevalence of vulvodynia among women referred to our institution for a suspected diagnosis and to evaluate the efficacy of a multidimensional treatment plan. The primary outcome was the prevalence of vulvodynia following differential diagnosis. Secondary outcomes included: prevalence of the differential diagnoses, symptom resolution rate following treatment, and the relation between persistence of symptoms and (a) patients' age; (b) coexisting chronic overlapping pain conditions (COPCs). Results: After having ruled out all other causes of vulvar pain, only 40.1% of women were considered as affected by vulvodynia. The most frequent differential diagnoses included lower genital tract infections (25.3%), vulvar lichen sclerosus (17.6%) and vulvovaginal atrophy (8.2%). Following a multidisciplinary care program, resolution of symptoms was observed in 13.6% cases, improvement in 64.3% and persistence in 21.9%. We did not find a statistically significant association between persistence of symptoms and age > 38 years (OR 2.10; p = 0.30). Women with one or more COPCs other than vulvodynia had a 75% increased risk of not obtaining a resolution of symptoms (OR 1.75; p = 0.44). Conclusion: A thorough differential diagnosis and a multidisciplinary care program may represent a first way out of the muddle in the management of these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Biopsy‐verified vulvar lichen sclerosus: Incidence trends 1997–2022 and increased risk of vulvar squamous precancer and squamous cell carcinoma.
- Author
-
Baandrup, Louise, Hannibal, Charlotte G., Hertzum‐Larsen, Rasmus, and Kjær, Susanne K.
- Subjects
VULVAR cancer ,LICHEN sclerosus et atrophicus ,SQUAMOUS cell carcinoma ,PRECANCEROUS conditions - Abstract
Population‐based data on the epidemiology of vulvar lichen sclerosus (LS) are sparse and only few prospective studies have investigated the malignant potential of the disease. We used the nationwide Danish Pathology Registry to first assess the incidence of biopsy‐verified vulvar LS in the period 1997–2022 and second to examine the incidence of vulvar high‐grade squamous precancer and squamous cell carcinoma (SCC) in women with biopsy‐verified vulvar LS (1978–2019) compared with that expected in the general female population. For the latter aim, we computed standardized incidence ratios (SIRs) with 95% confidence intervals (CIs). During our study period, the age‐standardized incidence rate of vulvar LS increased from 5.0 (1997–1998) to 35.7 (2021–2022) per 100,000 person‐years. Compared with the general female population, women with biopsy‐verified vulvar LS had significantly increased rates of vulvar high‐grade squamous precancer (SIR = 8.5; 95% CI: 7.2–10.0) and SCC (SIR = 16.2; 95% CI: 14.2–18.4). The SIRs of vulvar high‐grade squamous precancer and SCC did not vary substantially according to length of follow‐up. This nationwide and population‐based study shows a 7‐fold increase in the incidence of biopsy‐verified vulvar LS since 1997. Data also show that women with biopsy‐verified vulvar LS have 8.5 and 16 times higher than expected incidence of vulvar high‐grade squamous precancer and SCC, respectively. The substantially increased incidence of vulvar high‐grade squamous precancer and SCC following LS is important in relation to the clinical management and follow‐up of LS patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. The Role of Line-Field Confocal Optical Coherence Tomography in Detecting Extramammary Paget Disease Recurrences: A Pilot Diagnostic Study.
- Author
-
Diet, Gwendoline, Lenoir, Clément, Fontaine, Margot, Boussingault, Lucas, Orte Cano, Carmen, Mtimet, Lyna, Liénard, Danielle, Sanak, Dilara, Moulart, Florine, Bernardi, Dana, Trepant, Anne-Laure, Perez-Anker, Javiera, Puig, Susana, Malvehy, Josep, Cinotti, Elisa, Tognetti, Linda, Rubegni, Pietro, Perrot, Jean-Luc, Marmol, Véronique Del, and Suppa, Mariano
- Subjects
- *
LICHEN sclerosus et atrophicus , *OPTICAL coherence tomography , *SKIN imaging , *DISEASE relapse , *CLINICAL medicine - Abstract
Extramammary Paget disease (EMPD) is an uncommon adenocarcinoma of apocrine gland-rich areas, presenting significant diagnostic challenges due to its nonspecific clinical appearance and frequent misidentification as benign, inflammatory skin conditions. Traditional diagnostic methods such as biopsy are invasive and uncomfortable, often required repeatedly due to high recurrence rates. Dermoscopy and non-invasive imaging techniques have been used but provide limited diagnostic accuracy due to their constraints in depth penetration and resolution. Recent advancements in imaging technologies, such as line-field confocal optical coherence tomography (LC-OCT), show promise in enhancing diagnostic precision while minimizing invasive procedures. LC-OCT merges high-resolution imaging with deep penetration capabilities, capturing detailed horizontal and vertical skin images akin to histopathology. This study evaluated the diagnostic performance of LC-OCT in detecting EMPD and its recurrence in 17 clinically suspicious anogenital regions, belonging to six patients. Data were collected prospectively at the patient's bedside by an LC-OCT expert with poor training for EMPD, and, then, reviewed retrospectively by an independent LC-OCT expert with adequate training for EMPD and no concerns about time. The prospective examination yielded 64.7% accuracy (11 true results out of 17 total cases), 71.4% sensitivity (10 true positives out of 14 actual positives), and 33.3% specificity (1 true negative out of 3 actual negatives). The retrospective analysis achieved 94.1% accuracy (16 true results out of 17 total cases), 100% sensitivity (14 true positives out of 14 actual positives), and 66.7% specificity (2 true positives out of 3 actual positives), with the only false positive case being a difficult-to-diagnose concomitant presentation of a lichen sclerosus et atrophicus. Despite the need for specialized training, our results suggest that LC-OCT represents a valuable tool for accurately identifying EMPD and improving its management by reducing unnecessary biopsies. Further studies are needed to standardize its clinical application. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Genital calcinosis cutis: Microscopic evidence supporting a dystrophic origin.
- Author
-
Crockett, Jessica L., Copp, Hillary L., Mully, Thaddeus W., Francois, Rony A., and Cordoro, Kelly M.
- Subjects
- *
CALCINOSIS cutis , *LICHEN sclerosus et atrophicus , *IDIOPATHIC diseases , *VULVAR diseases , *CALCIUM salts , *VULVAR cancer , *VULVA - Abstract
Calcinosis cutis (CC) is characterized by the deposition of calcium salts in the skin and subcutaneous tissues. CC involving the vulva or foreskin (prepuce) is uncommon. We present a 9‐year‐old female with vulvar CC and a 15‐year‐old male with preputial CC. Microscopic review of excisional specimens revealed calcification associated with follicular cysts in the vulvar case and lichen sclerosus in the preputial case, suggesting a dystrophic origin to a subset of cases of genital CC that might otherwise be classified as idiopathic. The clinical implication of these findings is the need for close histopathologic scrutiny and ongoing clinical surveillance of patients with genital CC initially deemed idiopathic. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Vulvar lichen sclerosus in female children.
- Author
-
Kalmi, Noura, Baybay, Hanane, Choukri, Souad, Douhi, Zakia, Elloudi, Sara, Soughi, Meryem, Kouskous, Faical, Kojmane, Widade, Hida, Moustapha, and Mernissi, Fatima Zahra
- Subjects
- *
CHILD patients , *LICHEN sclerosus et atrophicus , *AGE of onset , *POSTMENOPAUSE , *WOMEN patients - Abstract
Background: Vulvar lichen sclerosus (VLS) is an uncommon inflammatory dermatosis affecting the anogenital region. There are two peaks of incidence: one in prepubertal girls and the other in postmenopausal women. Its etiopathogenesis remains unknown. Objective: The objective was to specify the clinical characteristics of VLS in the female pediatric population in order to plan early treatment. Results: A total of 12 pediatric female patients were identified in the study. The mean age of onset was six years. Numerous potential etiological factors for VLS development were identified. Pruritus was the main symptom in a significant proportion of the patients. All patients had a good response to topical therapy with no significant side effects. Conclusion: VLS should be suspected in the presence of chronic vulvar pruritus in order to avoid tragic repercussions in adulthood. Appropriate treatment for each patient is essential as is the prevention of the side effects of applied treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Effect of Health Status and Heat-Induced Inactivation on the Proteomic Profile of Plasma Rich in Growth Factors Obtained from Donors with Chronic Inflammatory Skin Conditions.
- Author
-
Anitua, Eduardo, Tierno, Roberto, Azkargorta, Mikel, Elortza, Félix, and Alkhraisat, Mohammad H.
- Subjects
- *
LICHEN sclerosus et atrophicus , *SKIN inflammation , *ATOPIC dermatitis , *COMPLEMENT inhibition , *COMPLEMENT activation - Abstract
Atopic dermatitis, psoriasis and lichen sclerosus are among the most challenging conditions treated by dermatologists worldwide, with potentially significant physical, social and psychological impacts. Emerging evidence suggests that autologous-platelet-rich plasma could be used to manage skin inflammation. However, the presence of soluble autoimmune components could hinder their therapeutic potential. The aim of this study was to analyze the proteomic profile of plasma rich in growth factors (PRGFs) obtained from donors with inflammatory skin conditions to evaluate the impact of skin health status on the composition and bioactivity of PRGF-based treatments. Venous blood from healthy volunteers and patients with psoriasis, lichen sclerosus and atopic dermatitis was processed to produce PRGF supernatant. Half of the samples were subjected to an additional thermal treatment (56 °C) to inactivate inflammatory and immune molecules. Proteomic analysis was performed to assess the protein profile of PRGFs from healthy and non-healthy patients and the effect of Immunosafe treatment. Differential abundance patterns of several proteins related to key biological processes have been identified, including complement activation, blood coagulation, and glycolysis- and gluconeogenesis-related genes. These results also demonstrate that the thermal treatment (Immunosafe) contributes to the inactivation of the complement system and, as a consequence, reduction in the immunogenic potential of PRGF products. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. 104th Annual Meeting of the British Association of Dermatologists.
- Subjects
- *
IMMUNE reconstitution inflammatory syndrome , *SKIN cancer , *MEDICAL students , *MEDICAL personnel , *MEDICAL care , *POSITRON emission tomography computed tomography , *LICHEN sclerosus et atrophicus - Abstract
This document is a collection of abstracts and summaries of studies and articles in the field of dermatology. It covers a wide range of topics including sustainability practices in skin surgery units, the prevalence and risk factors of hidradenitis suppurativa, the use of telemedicine in dermatology during the COVID-19 pandemic, the impact of atopic dermatitis on parental sleep, and various medical conditions, treatments, and historical perspectives in dermatology. The document provides valuable insights into the understanding, management, and treatment of dermatological conditions, but further research is needed to fully explore the effectiveness and potential of these approaches. [Extracted from the article]
- Published
- 2024
18. Patient satisfaction and sexual issues in vulvar lichen sclerosus treatment: a monocentric certified dysplasia unit survey analysis.
- Author
-
Meyer-Wilmes, Philipp, Wittenborn, Julia, Kupec, Tomáš, Caspers, Rebecca, Stickeler, Elmar, and Iborra, Séverine
- Subjects
- *
PATIENT satisfaction , *LICHEN sclerosus et atrophicus , *SEXUAL excitement , *VULVAR diseases , *COVID-19 pandemic , *DYSPLASIA , *PATIENT surveys - Abstract
Objective: Vulvar lichen sclerosus (VLS) is an underestimated chronic disease. It can cause significant symptom burden and sexual dysfunction. This study aimed to evaluate patient satisfaction and current challenges in the management of VLS in a certified dysplasia unit, particularly during the COVID-19 pandemic. Methods: This survey analyzed patients who had been diagnosed with VLS and treated at our DKG-certified dysplasia unit. The study was conducted during the COVID-19 pandemic in the Department of Gynecology and Obstetrics at the University of Aachen. The questionnaire contained 43 questions on general treatment, diagnostic delays, disease education, psychologic and sexual issues, and specific questions regarding the COVID-19 pandemic. The questionnaires were distributed between January 2021 and September 2023. Results: This study included 103 patients diagnosed with VLS, who were treated at our certified dysplasia unit. Overall, 48% of the patients were satisfied with the success of the therapy. Most participants reported psychologic problems (36.8%), fear of cancer (53.3%), or sexual restrictions (53.3%). Among the patients, 38% were bothered by the regular application of topical cortisone. However, 72% were willing to undergo treatment for more than 24 months. The COVID-19 outbreak in March 2020 had a significant negative impact on general VLS care from the patient's perspective (3.83/5 before vs. 3.67/5 after; p = 0.046). There was a general request for booklets to inform and educate the patients about their disease. Furthermore, the respondents demanded a telephone hotline to answer the questions and wished for follow-up visits via e-mail to cope better with their current situation. Conclusion: This study highlights the need for more effective treatments for VLS and an increased awareness of psychologic and sexual distress. To ensure patient well-being and satisfaction, it is imperative to offer individualized care with adequate disease education in a team of specialists from various disciplines. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Acral Folliculocentric Extragenital Lichen Sclerosus: A Case Report.
- Author
-
Al-Husain, Khalid M, Madani, Abdulaziz, Alhumidi, Ahmed, Alsehli, Turky, and Nagshabandi, Khalid Nabil
- Subjects
LICHEN sclerosus et atrophicus ,SKIN biopsy ,SKIN diseases ,POSTMENOPAUSE ,PHYSICIANS - Abstract
Introduction: Lichen sclerosus is a chronic inflammatory dermatological condition of unknown etiology, primarily impacting the genital epidermis in individuals of all genders, with a higher prevalence observed among postmenopausal women and prepubescent girls. Additionally, extragenital manifestations occur in approximately 20% of the patients diagnosed with genital lichen sclerosus. Notably, folliculocentric extragenital lichen sclerosus is rare and unusual, with only limited instances documented in existing literature. Case Description: We report a 33 years old lady presented with multiple asymptomatic lesions on the dorsal feet for 1 year and similar lesions on the left hand for 4 months. On examination: folliculocentric, shiny, atrophic papules coalescing into reticulated plaques over the dorsum of both feet and few shiny, flat-topped, pink papules over the dorsum of the left hand. A skin biopsy was performed and confirmed the diagnosis of extragenital lichen sclerosus. Conclusion: Acral folliculocentric extragenital lichen sclerosus is an unusual and rare clinical variant. Clinicopathologic correlation is necessary to establish the correct diagnosis. Contribution to the Literature: Herein, we present an unusual presentation of extragenital lichen sclerosus, and we highlight the importance of considering it in the differential diagnosis of guttate acral skin lesions. We also review and summarize relevant cases from the literature in hope to aid physicians, especially dermatologists, to consider and swiftly reach the diagnosis and offer appropriate management. We also hope to bring about new insights and broaden future research efforts regarding lichen sclerosus especially and atrophic skin disease in general. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Genital Lichen Sclerosus Mistaken for Child Sexual Abuse and Genital Mutilation.
- Author
-
Patil, Amit, Agarwal, Mukta, Kumar, Prabhat, Narang, Himanshi, and Ranjan, Shashank
- Subjects
CHILD sexual abuse ,LICHEN sclerosus et atrophicus ,SEX crimes ,CHILD abuse laws ,LAW enforcement ,TEENAGE girls - Abstract
Child sexual abuse is a severe and widespread problem across the globe. The sexual exploitation of children is incomparable whose dynamics are very unusual to that of adult sexual abuse and hence should be handled and investigated differently. Failure to misdiagnose sexual abuse can expose the children to the risk of further abuse and may lead to serious consequences. This case report describes the forensic examination of a 17-year-old girl who primarily presented to the obstetrics and gynecology department with complaints of episodic acute urinary retention and difficulty in passing urine. While evaluating her, the primary physicians observed complete adhesion and fusion of labia majora. This unusual presentation made the examining physicians suspicious of genital mutilation and child sexual abuse. The examination revealed that the labia majora was less appreciable and was fused like parchment-like skin with no visualization of labia minora, clitoris, hymen and vaginal opening. There were no fresh signs of injuries to the anogenital region and no evidence of any surgical procedure done in the recent past suspected to be of genital mutilation. The local examination findings and absence of signs of trauma or surgical scar marks disproved the suspicion of genital mutilation and sexual abuse. The patient's condition was diagnosed with lichen sclerosus et atrophicus, causing genital labial sclerosus. The attending physicians often mistake such conditions as signs of suspected sexual abuse and if not correctly identified, may invite unwarranted child abuse inquiry by law enforcement authorities. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Glans cap-preserving dorsal inlay-free graft augmentation technique for reconstruction of meatal stenosis and fossa navicularis strictures: Analysis of short-term functional outcomes.
- Author
-
Enganti, Bhavatej, Nanavati, Prashant, Sarma Madduri, Vijay Kumar, Wani, Amish, and Chiruvella, Mallikarjuna
- Subjects
PENIS surgery ,URETHRA surgery ,TRANSPLANTATION of organs, tissues, etc. ,GRANULOMA ,STENOSIS ,TREATMENT effectiveness ,RETROSPECTIVE studies ,DESCRIPTIVE statistics ,ORAL mucosa ,URINE ,SURGICAL complications ,URETHRA stricture ,REOPERATION ,PLASTIC surgery ,TREATMENT failure ,HEALTH outcome assessment ,LICHEN sclerosus et atrophicus ,HEMORRHAGE - Abstract
Introduction: Meatal stenosis and fossa navicularis strictures (FNSs) are commonly caused by lichen sclerosus and instrumentation. We present the technique and short-term functional outcomes of glans cap-preserving dorsal inlay-free graft augmentation for the reconstruction of meatal stenosis and FNS. Methods: This retrospective study analyzed patients with meatal stenosis and FNS who underwent glans cap-preserving dorsal inlay-free graft augmentation at our institute since 2019. The surgical technique included a ventral subcoronal approach, preservation and mobilization of the glans cap, a ventral midline urethrotomy incision over the stricture, and a dorsal midline meatotomy incision extending to the proximal normal urethral mucosa at the fossa navicularis, followed by dorsal inlay graft augmentation. During the follow-up, patients were periodically assessed for symptom scores, urinary flow rates (UFRs), and patient-reported outcomes. Results: A total of 26 patients with a mean age of 45 ± 15 years were assessed. The predominant cause of stricture was lichen sclerosus (n = 15; 58%). The mean stricture length was 3.8 ± 0.5 cm, 73% had a circumcised phallus, and an oral mucosa graft augmentation was performed in 22 (85%) patients. Notable postoperative complications included intractable meatal hemorrhage (n = 1) and glans suture granuloma (n = 1), which required intervention. At a mean follow-up of 40 months, there were four failures, of which one patient required redo-urethroplasty. The remaining patients (n = 22; 85%) showed improved symptom scores (P < 0.05), UFRs (P < 0.05), and satisfactory patient-reported outcomes. Conclusion: Glans cap-preserving dorsal inlay-free graft augmentation is a safe and feasible technique with satisfactory short-term functional outcomes for the management of meatal stenosis and FNS in carefully selected patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Regenerative medicine in the treatment of specific dermatologic disorders: a systematic review of randomized controlled clinical trials.
- Author
-
Jafarzadeh, Alireza, Pour Mohammad, Arash, Keramati, Haniyeh, Zeinali, Roya, Khosravi, Mina, and Goodarzi, Azadeh
- Subjects
- *
LICHEN sclerosus et atrophicus , *FIBROBLAST growth factor 2 , *CLINICAL trials , *RANDOMIZED controlled trials , *REGENERATIVE medicine , *EPIDERMOLYSIS bullosa ,KERATINOCYTE differentiation - Abstract
Aims and objectives: The aim of this study is to systematically review randomized controlled clinical trials (RCTs) studying various types of regenerative medicine methods (such as platelet-rich plasma, stromal vascular fraction, cell therapy, conditioned media, etc.) in treating specific dermatologic diseases. Rejuvenation, scarring, wound healing, and other secondary conditions of skin damage were not investigated in this study. Method: Major databases, including PubMed, Scopus, and Web of Science, were meticulously searched for RCTs up to January 2024, focusing on regenerative medicine interventions for specific dermatologic disorders (such as androgenetic alopecia, vitiligo, alopecia areata, etc.). Key data extracted encompassed participant characteristics and sample sizes, types of regenerative therapy, treatment efficacy, and adverse events. Results: In this systematic review, 64 studies involving a total of 2888 patients were examined. Women constituted 44.8% of the study population, while men made up 55.2% of the participants, with an average age of 27.64 years. The most frequently studied skin diseases were androgenetic alopecia (AGA) (45.3%) and vitiligo (31.2%). The most common regenerative methods investigated for these diseases were PRP and the transplantation of autologous epidermal melanocyte/keratinocyte cells, respectively. Studies reported up to 68.4% improvement in AGA and up to 71% improvement in vitiligo. Other diseases included in the review were alopecia areata, melasma, lichen sclerosus et atrophicus (LSA), inflammatory acne vulgaris, chronic telogen effluvium, erosive oral lichen planus, and dystrophic epidermolysis bullosa. Regenerative medicine was found to be an effective treatment option in all of these studies, along with other methods. The regenerative medicine techniques investigated in this study comprised the transplantation of autologous epidermal melanocyte/keratinocyte cells, isolated melanocyte transplantation, cell transplantation from hair follicle origins, melanocyte–keratinocyte suspension in PRP, conditioned media injection, a combination of PRP and basic fibroblast growth factor, intravenous injection of mesenchymal stem cells, concentrated growth factor, stromal vascular fraction (SVF), a combination of PRP and SVF, and preserving hair grafts in PRP. Conclusion: Regenerative medicine holds promise as a treatment for specific dermatologic disorders. To validate our findings, it is recommended to conduct numerous clinical trials focusing on various skin conditions. In our study, we did not explore secondary skin lesions like scars or ulcers. Therefore, assessing the effectiveness of this treatment method for addressing these conditions would necessitate a separate study. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. High-frequency ultrasonography: one of the modern imaging diagnostic methods in dermatology. Authors' own experience and review.
- Author
-
Cisoń, Hanna and Białynicki-Birula, Rafał
- Subjects
- *
ULTRASONIC imaging , *DIAGNOSTIC imaging , *SKIN disease diagnosis , *DERMATOLOGY , *WARTS , *EPIDERMAL cyst , *LICHEN sclerosus et atrophicus - Abstract
Introduction: High-frequency ultrasonography (HFUS) has emerged as a non-invasive and cost-effective diagnostic tool for evaluating the outcomes of dermatological therapeutic procedures. Aim: This manuscript presents a comprehensive collection of sonographic images depicting cutaneous lesions associated with various dermatoses, including verruca vulgaris, epidermoid cyst, maculopapular cutaneous mastocytosis and lichen sclerosus et atrophicus. Material and methods: Drawing from an extensive review of the existing literature and supported by empirical observations, the study highlights key sonographic attributes observable in both normal and pathological skin variants. Results: It has been demonstrated that individual skin lesions exhibit distinct characteristics on HFUS. Furthermore, ultrasonographic examination has proven to be valuable for the objective assessment of disease severity. Conclusions: Additionally, the study contributes to a deeper understanding of HFUS as a valuable tool in dermatological diagnostics. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Local Perineal Capillary Perforator Flaps: A Minimally Invasive Technique for the Correction of Vulvar Stenosis.
- Author
-
Caretto, Anna Amelia, Garganese, Giorgia, Fragomeni, Simona Maria, Tagliaferri, Luca, Fionda, Bruno, Scambia, Giovanni, and Gentileschi, Stefano
- Subjects
- *
PERFORATOR flaps (Surgery) , *STENOSIS , *PLASTIC surgery , *LICHEN sclerosus et atrophicus , *VULVAR cancer , *CAPILLARIES - Abstract
Background: Vulvar stenosis is a debilitating condition that compromises sexual function, urination, and the ability to undergo gynecological examinations. The purpose of this study is to describe the technique of capillary perforator perineal flaps (CPPF) for the correction of vulvar stenosis. Methods: We retrospectively examined patients with vulvar stenosis treated through surgical separation and reconstruction with CPPF. The procedure involved vulvar separation with the creation of a subsequent defect, repaired using a flap, harvested laterally to the labia majora including a capillary perforator and transferred through a subcutaneous tunnel to repair the vulvar defect. The functional outcome was evaluated with the Bradford scale, comparing the preoperative and postoperative scores using the Student's t-test. Results: thirteen patients were included, three with stenosis following treatment for vulvar cancer and ten due to lichen sclerosus. In total, we analyzed 29 flaps, with an average size of 15.6 cm2. We always included just one perforator in the flap and no postoperative complications. Stenosis was resolved in all patients, with no recurrences one year after the surgery. The preoperative average severity of the stenosis was 2.3 + 0.6, reducing to 0.3 + 0.4 post-intervention, indicating a significant improvement (p < 0.01). Conclusions: CPPF has proven to be a quick and safe method for the reconstruction of vulvar stenosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Is there a role for platelet rich plasma injection in vulvar lichen sclerosus? A self-controlled pilot study.
- Author
-
Boero, Veronica, Cetera, Giulia Emily, Caia, Carlotta, Villa, Stefania, Montemurro, Tiziana, Brambilla, Massimiliano, Monti, Ermelinda, Iorio, Maria, Somigliana, Edgardo, Vercellini, Paolo, and Prati, Daniele
- Subjects
- *
PLATELET-rich plasma , *LICHEN sclerosus et atrophicus , *PATIENT satisfaction , *PILOT projects , *INJECTIONS - Abstract
Background: Owing to the evidence that as many as 30–40% of patients with vulvar lichen sclerosus (VLS) fail to report a remission of symptoms with first-line corticosteroid treatment (TCS), especially as what regards dyspareunia, we aimed to analyze patients' satisfaction following vulvar injection of autologous platelet-rich plasma (PRP). This is intended as an adjunctive treatment, to be used following TCS, and appears to promote tissue repair. It may also possibly have immunomodulatory proprieties. Materials and methods: Patients with VLS were considered eligible for this pilot study if, despite having been treated with a 3-month TCS regimen, they reported a persistence of symptoms. PRP was produced in a referral center using a manual method and a standardized protocol. Each patient received three treatments 4 to 6 weeks apart. Results: A total of 50 patients with a median age of 53 years [IQR 38–59 years] were included in the study. 6 months after the last injection of PRP all patients were either satisfied or very satisfied with the treatment (100%; 95% CI 93–100%). Median NRS scores for itching, burning, dyspareunia and dysuria were significantly reduced (p < 0.05) and FSFI, HADS and SF-12 questionnaires revealed a significant improvement in sexual function, psychological wellbeing and quality of life (p < 0.05). The number of patients reporting the need for maintenance TCS treatment was reduced by 42% (p < 0.001) and an improvement in vulvar elasticity and color was reported in all patients. Conclusion: Following standard medical therapy, PRP may be effective not only in improving symptoms, but also in restoring function. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Diagnosis of verruciform acanthotic vulvar intra‐epithelial neoplasia (vaVIN) using CK17, SOX2 and GATA3 immunohistochemistry.
- Author
-
Cook, Eleanor, Van de Vijver, Koen, and Parra‐Herran, Carlos
- Subjects
- *
LICHEN sclerosus et atrophicus , *DIAGNOSIS , *TUMORS , *CANCER relapse , *DISEASE risk factors , *IMMUNOHISTOCHEMISTRY - Abstract
Aims: Verruciform acanthotic vulvar intra‐epithelial neoplasia (vaVIN) is an HPV‐independent, p53 wild‐type lesion with distinct morphology and documented risk of recurrence and cancer progression. vaVIN is rare, and prospective distinction from non‐neoplastic hyperplastic lesions can be difficult. CK17, SOX2 and GATA3 immunohistochemistry has emerging value in the diagnosis of HPV‐independent lesions, particularly differentiated VIN. We aimed to test the combined value of these markers in the diagnosis of vaVIN versus its non‐neoplastic differentials in the vulva. Methods and results: CK17, SOX2 and GATA3 immunohistochemistry was evaluated on 16 vaVINs and 34 mimickers (verruciform xanthoma, lichen simplex chronicus, lichen sclerosus, psoriasis, pseudo‐epitheliomatous hyperplasia). CK17 was scored as 3+ = full‐thickness, 2+ = partial‐thickness, 1+ = patchy, 0 = absent; SOX2 as 3+ = strong staining ≥ 10% cells, 2+ = moderate, 1 + =weak, 0 = staining in < 10% cells; and GATA3 as pattern 0 = loss in < 25% basal cells, 1 = loss in 25–75% basal cells, 2 = loss in > 75% basal cells. For analysis, results were recorded as positive (CK17 = 3+, SOX2 = 3+, GATA3 = patterns 1/2) or negative (CK17 = 2+/1+/0, SOX2 = 2+/1+/0, GATA3 = pattern 0). CK17, SOX2 and GATA3 positivity was documented in 81, 75 and 58% vaVINs, respectively, versus 32, 17 and 22% of non‐neoplastic mimickers, respectively; ≥ 2 marker positivity conferred 83 sensitivity, 88 specificity and 86% accuracy in vaVIN diagnosis. Compared to vaVIN, SOX2 and GATA3 were differentially expressed in lichen sclerosus, lichen simplex chronicus and pseudo‐epitheliomatous hyperplasia, whereas CK17 was differentially expressed in verruciform xanthoma and adjacent normal mucosa. Conclusions: CK17, SOX2 and GATA3 can be useful in the diagnosis of vaVIN and its distinction from hyperplastic non‐neoplastic vulvar lesions. Although CK17 has higher sensitivity, SOX2 and GATA3 are more specific, and the combination of all markers shows optimal diagnostic accuracy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus
- Author
-
Jennifer R. Arthurs, Sponsor-Investigator
- Published
- 2023
28. Does Steroid Plus CO2 Laser Improve Lichen Sclerosus Symptoms Compared to Steroids Alone?
- Published
- 2023
29. Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS) (Orchid 1)
- Published
- 2023
30. Comparison of Laser Treatment With Clobetasol Therapy in Patients With Lichen Sclerosus
- Published
- 2023
31. Lichen Sclerosus - Treatment With Triamcinolone Acetonide: Injections (Syringe and Needle) x Micro Injections (MMP Technique)
- Author
-
SAMIR ARBACHE, PHD
- Published
- 2023
32. Lichen Sclerosus—Incidence and Comorbidity: A Nationwide Swedish Register Study.
- Author
-
Jerkovic Gulin, Sandra, Lundin, Filippa, Eriksson, Olle, and Seifert, Oliver
- Subjects
- *
LICHEN sclerosus et atrophicus , *PRECANCEROUS conditions , *TESTICULAR cancer , *VULVAR cancer , *PENILE cancer , *COMORBIDITY , *BLADDER cancer - Abstract
Background: Data on the incidence and comorbidity of Lichen sclerosus (LS), based on validated nationwide population-based registries, remains scarce. Objective: To explore the incidence and association of comorbidities with LS in Sweden, emphasizing its potential links to malignancies and autoimmune disorders. Methods: A population-based retrospective open cohort study was conducted using the National Patient Register to identify all individuals diagnosed with LS (ICD-10 code L90.0) from 1 January 2001 to 1 January 2021. The study included 154,424 LS patients and a sex and age matched control group of 463,273 individuals to assess the incidence and odds ratios for various cancers and premalignant conditions. Results: The incidence of LS in Sweden was 80.9 per 100,000 person per year, with higher incidence in females (114.4) than in males (47.2). LS patients showed an increased odds ratio for vulvar cancer (OR = 8.3; 95% CI = 7.5–9.0), penile cancer (OR = 8.9; 95% CI = 7.3–11.0), prostate cancer (OR = 1.2; 95% CI = 1.1–1.2), testicular cancer (OR = 1.4; 95% CI = 1.1–1.7), bladder cancer (OR = 1.1; 95% CI = 1.1–1.2), breast cancer (OR = 1.4; 95% CI = 1.3–1.4), leukoplakia of the vulva (OR = 253.5; 95% CI = 221.9–289.6), and leukoplakia of the penis (OR = 5.1; 95% CI = 4.9–5.4). Conclusions: This study underscores the significantly increased association of various cancers and premalignant conditions in LS patients, highlighting the critical need for efficacious treatment and diligent follow-up. The association between LS and autoimmune diseases further necessitates comprehensive investigation to understand the underlying mechanisms and clinical management implications. Future research is essential to confirm these findings and elucidate the role of LS in cancer development. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Comedones in dermatology.
- Author
-
Najeeb, Aysha, Gaurav, Vishal, and Sharma, Ritu
- Subjects
- *
ACNE , *HAMARTOMA , *ACNEIFORM eruptions , *LICHEN sclerosus et atrophicus , *KERATOSIS follicularis , *DERMATOLOGY , *HIDRADENITIS suppurativa - Abstract
This document provides a comprehensive overview of comedones in dermatology, focusing on their formation, association with acne, and other dermatological conditions. It categorizes various skin disorders based on their association with comedones and includes a table summarizing these disorders. The document also discusses other skin disorders occasionally associated with comedones and provides information on dermoscopic features. It concludes with declarations of patient consent, financial support, conflicts of interest, and the non-use of artificial intelligence in manuscript preparation. This compilation of articles and studies is a valuable resource for library patrons conducting research on comedones and related skin conditions. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
34. Vulval dermatoses: A review of referrals to dermatology.
- Author
-
Warner, Sophie and Oakley, Amanda
- Subjects
- *
SKIN diseases , *VULVAR diseases , *LICHEN sclerosus et atrophicus , *DERMATOLOGY , *SKIN inflammation , *PSORIASIS - Abstract
We undertook a retrospective observational review of patients referred to a tertiary dermatology department with vulval complaints over 12 months. The most common provisional diagnoses made by the referrer and final dermatology diagnoses were lichen sclerosus (54% and 38%), dermatitis (12.7% and 16.5%) and psoriasis (5.1% and 6.3%). Referrers may benefit from further education about skin diseases of the vulva, topical steroids for vulval complaints and the importance of clinical photography. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Quality of life and burden of disease of vulvar lichen sclerosus: A single‐center retrospective study in China.
- Author
-
He, Yuexi, Liu, Lin, Yang, Kun, Sun, Kailv, Zhang, Qiuli, Yang, Min, and Chang, Jianmin
- Subjects
- *
LICHEN sclerosus et atrophicus , *VULVAR diseases , *VULVAR cancer , *QUALITY of life , *AGE of onset , *RETROSPECTIVE studies , *VULVA - Abstract
Objective: This study examined the quality of life and burden of disease of vulvar lichen sclerosus (VLS) patients in three states of menstruation to better understand VLS. Methods: A total of 607 VLS patients were enrolled into this retrospective study. According to the ages of onset, menarche and menopause, the patients were divided into three groups: prepubertal group (n = 96), reproductive group (n = 400) and postmenopausal group (n = 111). Data were collected by direct interview and clinical examination. Results: A total of 93% of patients had itching, with a median numerical rating scale score of five. In the prepubertal group, the median score was three. Nocturnal itching occurred in 49.6% patients. Nearly half of the patients (45.9%) thought the itching affected their sleep. However, this ratio was very different in the prepubertal group (20.7%). Some patients (12.8%) cleaned their vulva more than seven times per week. Only 17.2% of patients experienced no effect on their sex life. The median dermatology life quality index score in all patients was six, but it was only three in the prepubertal group. The median number of hospital visits was two times, and the number of clinic visits was three times. Previous expenses, in median, were 2000 RMB. For 84.3% patients, the gynecologic clinic was their first choice. Conclusion: VLS places great physical, mental and economic burdens on patients. Patients in the prepubertal group had milder symptoms and dermatology life quality index score. VLS should arouse the attention of patients and specialists. Synopsis: Vulvar lichen sclerosus leads to a decrease in patient's quality of life and places great economic burdens on patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Nd:YAG/Er:YAG dual laser compared with topical steroid to treat vulvar lichen sclerosus: A randomised controlled trial.
- Author
-
Zivanovic, Irena, Gamper, Marianne, Fesslmeier, Debra, Walser, Claudia, Regauer, Sigrid, and Viereck, Volker
- Subjects
- *
VULVAR cancer , *LICHEN sclerosus et atrophicus , *RANDOMIZED controlled trials , *LASERS , *LASER therapy , *PATIENT satisfaction - Abstract
Objective: To evaluate the efficacy and safety of a novel non‐ablative Nd:YAG/Er:YAG dual laser treatment for vulvar lichen sclerosus (LS) in comparison with the recommended first‐line therapy with topical steroid. Design: A randomised investigator‐initiated active‐controlled trial. Setting: Single tertiary referral centre. Population: Women with vulvar LS. Methods: Randomisation (2:1) to Nd:YAG/Er:YAG laser therapy or topical clobetasol proprionate therapy. Four laser treatments at 0, 1, 2 and 4 months or decreasing doses of steroid for 6 months. Main Outcome Measures: The primary outcome was the change in objective validated clinical LS score in the laser arm between baseline and 6 months. Secondary outcomes were laser tolerability/safety, symptom scores and patient satisfaction. Results: Sixty‐six women were included, 44 in the laser group and 22 in the steroid group. The total LS score decreased by −2.34 ± 1.20 (95% CI −2.71 to −1.98) in women treated with laser compared with a decrease of −0.95 ± 0.90 (95% CI −1.35 to −0.56) in those receiving steroid applications (p < 0.001). Laser treatment was safe and well tolerated. Subjective severity scores (on visual analogue scale) and vulvovaginal symptoms questionnaire scores improved similarly for the laser and steroid arms without significant differences between the two treatments. Patient satisfaction was higher in the laser arm than in the steroid arm (p = 0.035). Conclusions: Non‐ablative dual Nd:YAG/Er:YAG laser therapy was safe and significantly improved clinical outcome and subjective symptoms at the 6‐month follow up. This suggests that laser may be a promising alternative to corticosteroid therapy. However, the authors caution regular follow ups because of the premalignant nature of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Application of a diagnosis flow draft based on appearance impression for detection of vulvar disease.
- Author
-
Zhou, Qi, Chen, Fang, Wang, Yan, Qu, Wenjie, Gong, Yingxin, Cao, Yuankui, Zhang, Hongwei, Wang, Qing, Chen, Limei, Cong, Qing, Lin, Lin, Mo, Jiayin, Bi, Tianyi, Ding, Jingxin, Sui, Long, and Li, Yanyun
- Subjects
- *
VULVAR cancer , *VULVAR diseases , *CERVICAL intraepithelial neoplasia , *DIAGNOSIS , *LICHEN sclerosus et atrophicus , *INTERNATIONAL organization - Abstract
The aims of this retrospective study were to evaluate the clinical applicability of the latest International Society for the Study of Vulvovaginal Disease (ISSVD) and International Federation for Cervical Pathology and Colposcopy (IFCPC) terminology for vulvar diseases, and to explore a new evaluation flow to optimize decision-making on diagnosis. A total of 1,068 patients with 5,340 qualified vulvar images were evaluated by observers using 2011 ISSVD and 2011 IFCPC terminology systems. The sensitivity, specificity, positive predictive value, negative predictive value, Youden Index and Overall Diagnostic Value (ODV) were calculated for each finding in the two systems. Then the disease diagnosis order and a diagnosis flow draft (DFD) were obtained. A total of 15 kinds of vulvar diseases were diagnosed. The proportion of patients accompanied with cervical or vaginal intraepithelial neoplasia was highest (83.3 %) in vulvar Paget's disease group (p<0.001). Total area of lesions was larger in vulvar Paget's disease, lichen simplex chronicus and lichen sclerosus group (p<0.001). Among the top five findings of ODV, some findings inferred several (≥6) kinds of diseases, while some findings only exist in a certain disease. When the DFD was used, the agreement between the initial impression and histopathology diagnosis was 68.8 %, higher than those when ISSVD an IFCPC terminology systems used (p=0.028), and it didn't change with the experience of the observer (p=0.178). Based on the findings in ISSVD and IFCPC terminology systems, we explored a DFD for observers with different experience on the detection of vulvar disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Exclusive extragenital lichen sclerosis in a child presenting in a lichen planus distribution.
- Author
-
Murshidi, Rand, AlSamhori, Jehad Feras, AlSamhouri, Abdel Rahman Feras, Hamad, Salsabiela Bani, Abdaljaleel, Maram, and AlShammas, Faris
- Subjects
LICHEN sclerosus et atrophicus ,LICHEN planus ,POSTMENOPAUSE ,HYPERPIGMENTATION ,CORTICOSTEROIDS - Abstract
Lichen sclerosus (LS) is a chronic inflammatory dermatosis primarily affecting the genitalia, commonly characterized by pearly-white papules and plaques. Although predominantly affecting females, LS can manifest across all age groups, with a bimodal distribution observed in prepubescent girls and postmenopausal women. This case report presents an unusual instance of exclusive extragenital LS in a 10-year-old girl, showcasing hyperpigmented patches and wrinkled plaques resembling lichen planus on her forearms and lower legs. Histopathological analysis confirmed LS, revealing distinctive epidermal changes and lymphocytic infiltrates. The absence of mucosal involvement and unique clinical presentation differentiated this case from typical LS manifestations. Treatment with topical clobetasol propionate demonstrated significant improvement in pruritus. Extragenital LS is infrequent, particularly among children, and its diagnosis necessitates a comprehensive clinicopathological correlation. The reported case contributes valuable insights into this uncommon variant, emphasizing the importance of accurate diagnosis and tailored treatment strategies. Additionally, it highlights the efficacy of highpotency topical corticosteroids in managing this condition. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Lichen sclerosus bei klinisch relevanter Phimose: Häufigkeit, Risikofaktoren und Assoziation mit Plattenepithelkarzinomen des Penis.
- Author
-
Schulenburg, Benita S., Hook, Sophia, Becker, Mareike, Becker, Benedikt, Gross, Andreas J., Filmar, Simon, and Rosenbaum, Clemens M.
- Subjects
DIABETES complications ,SQUAMOUS cell carcinoma ,RISK assessment ,PENILE tumors ,BODY mass index ,CORONARY disease ,LOGISTIC regression analysis ,CIRCUMCISION ,RETROSPECTIVE studies ,AGE distribution ,DESCRIPTIVE statistics ,ODDS ratio ,MEN'S health ,PULMONARY arterial hypertension ,COMPARATIVE studies ,PHIMOSIS ,LICHEN sclerosus et atrophicus ,DISEASE incidence ,DISEASE risk factors ,DISEASE complications - Abstract
Copyright of Die Urologie is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
40. Alternations in the human skin, gut and vaginal microbiomes in perimenopausal or postmenopausal Vulvar lichen sclerosus.
- Author
-
Ma, Xiaolei, Wen, Guangdong, Zhao, Zheng, Lu, Lulu, Li, Tianying, Gao, Na, and Han, Gangwen
- Subjects
- *
LICHEN sclerosus et atrophicus , *PENTOSE phosphate pathway , *AMINO acid metabolism , *PERIMENOPAUSE , *BACTEROIDES fragilis , *QUALITY of life , *LICHENS - Abstract
Vulvar lichen sclerosus (VLS) is a chronic and progressive dermatologic condition that can cause physical dysfunction, disfigurement, and impaired quality of life. However, the etiology of VLS remains unknown. The vulvar skin, intestinal and vaginal microbiomes have been postulated to play important roles in the pathogenesis of this disease. The aim of this study was to compare the compositional characteristics of the vulvar skin, vagina, and gut microbiota between perimenopausal or postmenopausal VLS patients and healthy controls. The study involved six perimenopausal or postmenopausal VLS patients which were based on characteristic clinical manifestations and histologic confirmation and five healthy controls. The pruritus severity of each patient was evaluated using the NRS scale, and the dermatology-specific health-related quality of life was assessed using the Skindex-16. Metagenomic sequencing was performed, and the results were analyzed for alpha and beta diversity. LEfSe analysis were used to investigate the microbial alterations in vulvar skin, gut and vagina. KEGG databases were used to analyze differences in functional abundance. The study found significant differences in alpha diversity between the two groups in stool and vaginal samples (P < 0.05). Patients with VLS had a higher abundance of Enterobacter cloacae, Flavobacterium_branchiophilum, Mediterranea_sp._An20, Parabacteroides_johnsoniiand Streptococcus_bovimastitidis on the vulvar skin, while Corynebacterium_sp._zg-913 was less abundant compared to the control group. The relative abundance of Sphingomonas_sp._SCN_67_18, Sphingobium_sp._Ant17, and Pontibacter sp BT213 was significantly higher in the gut samples of patients with VLS.Paenibacillus_popilliae,Gemella_asaccharolytica, and Coriobacteriales_bacterium_DNF00809 compared to the control group. Additionally, the vaginal samples of patients with VLS exhibited a significantly lower relative abundance of Bacteroidales_bacterium_43_8, Bacteroides_sp._CAG:20, Blautia_sp._AM28-10, Fibrobacter_sp._UWB16, Lachnospiraceae_bacterium_AM25-39, Holdemania_filiformis, Lachnospiraceae_bacterium_GAM79, and Tolumonas_sp. Additionally, the butyrate-producing bacterium SS3/4 showed a significant difference compared to the controls. The study found a negative relationship between Sphingobium_sp._Ant17 in stool and Skindex-16 (P < 0.05), while Mediterranea_sp._An20 had a positive correlation with Skindex-16 (P < 0.05) in the skin. Additionally, our functional analysis revealed alterations in Aminoacyl_tRNA_biosynthesis, Glutathione_metabolism, the pentose phosphate pathway, and Alanine__aspartate_and_glutamate_metabolism in the VLS patient group. The study suggests that perimenopausal or postmenopausal patients with VLS have a modified microbiome in the vulvar skin, gut, and vagina. This modification is linked to abnormal energy metabolism, increased oxidative stress, and abnormal amino acid metabolism. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. IL-17: a novel player in the pathogenesis of vulvar lichen sclerosus.
- Author
-
Baran, Wojciech, Woźniak, Zdzisław, and Batycka-Baran, Aleksandra
- Subjects
- *
INTERLEUKIN-17 , *LICHEN sclerosus et atrophicus , *EPIDERMIS , *SKIN biopsy , *IMMUNOHISTOCHEMISTRY - Abstract
Introduction: Vulvar lichen sclerosus (VLS) is a chronic progressive, lymphocyte-mediated inflammatory disease whose pathogenesis is complex and not fully elucidated. Aim: In the current study we have investigated for the first time the expression of interleukin-17 (IL-17) and S100A7 in lesional skin obtained from female individuals with histologically confirmed VLS. Material and methods: In our study we used skin biopsies obtained from female patients with histologically confirmed VLS (n = 20) and skin samples from healthy age- and gender-matched individuals (plastic surgery procedures) (n = 10) serving as controls. The tissue expressions of IL-17 and S100A7 were assessed with an immunohistochemical method. Results: The number of cells showing IL-17 expression was significantly higher in VLS lesional skin as compared to normal skin of healthy controls (p < 0.0001). In VLS lesional skin, IL-17 was expressed in the epidermis and by cells within the inflammatory infiltrate in the upper dermis. The number of cells showing S100A7 expression was significantly higher in VLS lesional skin as compared to normal skin of healthy controls (p < 0.0001). In VLS lesional skin, S100A7 was expressed by suprabasal keratinocytes in epidermis. S100A7 was also expressed by cells within the inflammatory infiltrate in the dermis. Conclusions: The results of our study may suggest the involvement of IL-17 and S100A7 in the pathogenesis of VLS. The better understanding of this disease may lead to the development of novel, effective therapeutic strategies e.g. using well-known biologics IL-17 inhibitors class. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Causal Association Between Diabetes, Body Mass Index and Lichen Sclerosus: A Bidirectional Two-Sample Mendelian Randomization Analysis.
- Author
-
Liu, Lin, Zhang, Qiuli, Chang, Jianmin, and Yang, Kun
- Subjects
BODY mass index ,LICHEN sclerosus et atrophicus ,TYPE 1 diabetes ,TYPE 2 diabetes ,GENOME-wide association studies - Abstract
Background: Previous observational studies have found that lichen sclerosus (LS) is associated with metabolic statuses, such as diabetes mellitus (DM) and body mass index (BMI). However, there are also some studies showing that LS is not related to DM and BMI. The mechanism behind observational results is still unclear. Therefore, the causality of this relationship remains unknown. In this study, a bidirectional two-sample Mendelian randomization (MR) was conducted to investigate the correlation between DM, BMI, and LS. Methods: The instrumental variables related to DM (including type 1 and type 2 diabetes), and BMI were identified from genome-wide association studies (GWAS) and a GWAS meta-analysis. The GWAS data for LS was from obtained the eighth edition of the FinnGen biological database released in 2022. Inverse variance weighted (IVW), weighted median, and MR-Egger methods were used to conduct a bidirectional two-sample MR analysis. Thereafter, the heterogeneity and horizontal pleiotropy were examined to determine whether the results were affected by a single-nucleotide polymorphism (SNP). Results: We found a lack of evidence for the causal association of DM, and BMI on LS in inverse variance weighted (type 1 diabetes, OR=0.97, 95% CI=0.91– 1.04, p=0.429; type 2 diabetes, OR=0.91, 95% CI=0.82– 1.00, p=0.0511; BMI, OR=0.92, 95% CI=0.73– 1.15, p=0.4554). In the other direction, the results also showed that LS had no significant causal effect on DM and BMI. Conclusion: This MR analysis demonstrated no significant causal relationship between DM and BMI with LS in both directions, which contradicts previous observational studies reporting a positive association. Potential confounding factors may contribute to previously observed associations, and further research is necessary. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Genitourinary Syndrome of Menopause: Pathophysiology, Clinical Presentation, and Differential Diagnosis.
- Author
-
CLARK, AMANDA L. and GOETSCH, MARTHA F.
- Subjects
- *
GENITOURINARY disease diagnosis , *MENOPAUSE treatment , *ESTROGEN replacement therapy , *FEMALE reproductive organ diseases , *DIFFERENTIAL diagnosis , *BACTERIAL vaginitis , *CROHN'S disease , *MENOPAUSE , *GENITOURINARY diseases , *VULVODYNIA , *VAGINITIS , *VULVOVAGINAL candidiasis , *LICHEN planus , *HORMONE therapy , *VAGINAL discharge , *DYSPAREUNIA , *LICHEN sclerosus et atrophicus - Abstract
Scientific information is incomplete regarding the genitourinary syndrome of menopause. Both the lower genital and urinary tracts are rich in receptors for reproductive hormones and are highly susceptible to waning ovarian hormones at menopause. Symptoms of dryness and pain emerge in late perimenopause, but they can also result earlier from cancer therapies or bilateral oophorectomy. Lower urinary tract symptoms rise in prevalence at midlife and increase further with advancing age. Because ovarian senescence is typically followed by years of aging, some postmenopausal complaints may be attributable to increasing longevity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. The Need of Differential Diagnosis Between Vulvar Lichen Sclerosus and Autoimmune Dermatoses in Adolescent Girls.
- Author
-
Dulska, Agnieszka, Bodziony, Jakub, Janik, Marta, and Drosdzol-Cop, Agnieszka
- Subjects
- *
VULVAR diseases , *LICHEN sclerosus et atrophicus , *MEDICAL care , *MEDICAL personnel , *TEENAGE girls , *SKIN diseases , *EPIDERMOLYSIS bullosa - Abstract
Introduction: Vulvar lichen sclerosus (VLS) is a chronic inflammatory condition affecting the anogenital region, which can manifest in prepubertal or adolescent patients. The prevailing theories point to autoimmune and genetic factors. The primary symptoms of VLS typically include vulvar itching, discomfort, dysuria, and constipation. Physical examination often reveals a characteristic figure 8 pattern, involving the labia minora, clitoral hood, and perianal region. However, these symptoms and the age of onset are nonspecific and require differentiation from autoimmune dermatoses such as bullous diseases, pemphigus diseases, epidermolysis bullosa acquisita, and dermatitis herpetiformis. We performed this study to distinguish VLS from autoimmune dermatoses, and in doing so, uncover the underlying causes of chronic vulvar changes. This knowledge will enable healthcare providers to offer appropriate medical care to affected patients. Methods: The study was conducted between July 2020 and February 2021, with a sample of 55 girls aged 2–18 years who did not have any systemic diseases. The study group was composed of 20 girls previously diagnosed with vulvar lichen sclerosus, while the control group included 35 girls without VLS. Questionnaires regarding the medical history of the children were completed by their legal guardians. Blood samples were collected and analyzed biochemically to assess human immunoglobulin A (IgA), IgG, and IgM antibodies against various substrates, including the desmosome of stratum spinosum, basement membrane zone, desmoglein 1 (DSG1), desmoglein 3 (DSG3), BP180-NC16A-4X, BP230gC, pemphigoid antigen, collagen type VII NC1, transitional epithelium, gliadin (GAF-3X), endomysium (EMA), and cellular nucleus (ANA). Results: The analysis of the study group revealed that the most commonly observed signs and symptoms included: itching, soreness, burning sensations, and excoriation, as well as erythema or/and pallor of the skin and perineal mucosa. Among the assessed antibodies, only anti-GAF3x antibodies and ANA antibodies were detected. However, the results did not reach statistical significance (p > 0.5). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Reflectance confocal microscopy as a complementary diagnostic tool for vulvar lichen sclerosus and vulvar vitiligo in juvenile Chinese girls.
- Author
-
Wang, Ying, Chen, Lixin, Qin, Bei, Ren, Min, and Li, Qinfeng
- Subjects
- *
LICHEN sclerosus et atrophicus , *VULVAR diseases , *CHINESE people , *CONFOCAL microscopy , *VITILIGO , *REFLECTANCE , *GIRLS , *JUVENILE offenders - Abstract
This article discusses the use of reflectance confocal microscopy (RCM) as a diagnostic tool for vulvar lichen sclerosus (VLS) and vulvar vitiligo (VV) in juvenile Chinese girls. VLS and VV have similar clinical appearances, but RCM can reveal distinct features that aid in diagnosis. The study examined 28 patients, with 17 having VLS and 11 having VV. The results showed that VLS is characterized by structural disorder, fibrous material deposits, and larger cellular structures, while VV is characterized by weakened dermal papillary rings. The authors suggest that RCM can be used to support clinical diagnosis of VLS and VV. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
46. Lichen Sclerosus et Atrophicus: The Importance of Early Diagnosis and Treatment and Comprehensive Care.
- Author
-
Nellis, Julia and Gardner, Kenzie
- Subjects
VULVAR diseases ,SQUAMOUS cell carcinoma ,ADRENOCORTICAL hormones ,CUTANEOUS therapeutics ,SKIN diseases ,DIFFERENTIAL diagnosis ,DERMATOLOGIC agents ,PRIMARY health care ,EARLY diagnosis ,VULVA ,LICHEN sclerosus et atrophicus ,DISEASE risk factors - Abstract
Lichen sclerosus (LS) et atrophicus et atrophicus, commonly referred to as LS, is a relatively uncommon chronic inflammatory condition that typically affects the skin of the vulvar and perianal regions but can involve extragenital areas. This review will focus primarily on vulvar LS. Although LS can affect men and prepubescent patients, LS has a much higher incidence in women over the age of 30 years. When correctly diagnosed and treated in its earlier stages, LS, although still chronic, is manageable with the appropriate protocol. When left untreated or poorly managed, LS can progress to its later "atrophic" stages and cause severe lichenification, atrophy, and destructive scarring, resulting in the loss of normal anatomic landmarks and function of the genitals. In addition, both men and women with genital LS have an increased risk of developing squamous cell carcinoma in the affected skin. In women, 65% of genital squamous cell carcinomas arise from a preexisting lesion from LS. This can negatively affect a patient's sleep and physical, mental, and social/emotional health. Increased awareness of the presentation and symptoms, in both providers and patients, of LS et atrophicus encourages earlier treatment and management while preventing long-term, irreversible physical, mental, and emotional damage. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Conservative Management of Penile and Urethral Lichen Sclerosus: A Systematic Review.
- Author
-
Shieh, Christine, Hakam, Nizar, Pearce, Robert J., Nagpal, Meera, Ghaffar, Umar, Guzman, Jose L., Abbasi, Behzad, Shaw, Nathan M., Jones, Charles P., Breyer, Benjamin N., and Johnsen, Niels V.
- Abstract
Purpose: We evaluate the efficacy and safety profiles of currently available conservative management options for penile and urethral lichen sclerosus. Materials and Methods: A systematic review of existing literature on lichen sclerosus was conducted utilizing the PubMed, Embase, and Web of Science databases. References were assessed for relevance to nonsurgical management of male genital lichen sclerosus by title and abstract by 3 independent reviewers, then reviewed in full and in duplicate by 5 independent reviewers. Results: Seventeen studies describing conservative management of histologically confirmed penile and urethral lichen sclerosus in male patients were included in the final review. We present available evidence supporting the use of 4 major treatment modalities represented in the existing literature: topical corticosteroids, tacrolimus, platelet-rich plasma, and CO2 laser. We also briefly discuss the limited studies on the use of oral acitretin and polydeoxyribonucleotide injections. Outcomes assessed include symptoms, clinical appearance, quality of life, sexual satisfaction, adverse effects, and long-term efficacy of treatment. Conclusions: Topical corticosteroids remain the mainstay of conservative management of penile and urethral lichen sclerosus, with current literature supporting the use of other therapies such as tacrolimus and platelet-rich plasma as alternatives or adjuvant treatments when escalation of treatment is necessary. Future research should further explore the efficacy and safety of newer therapies through additional controlled clinical trials in the targeted population. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Searching for a "Window of Opportunity" in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment.
- Author
-
Borghi, Alessandro, Flacco, Maria Elena, Schettini, Natale, Toni, Giulia, and Corazza, Monica
- Subjects
LICHEN sclerosus et atrophicus ,VULVAR diseases ,CORTICOSTEROIDS ,SYMPTOMS ,LOGISTIC regression analysis ,DISEASE progression - Abstract
Introduction: Vulvar lichen sclerosus (VLS) is characterized by progressive anatomical changes which become increasingly severe and irreversible. The objective of this study was to investigate if a "window of opportunity" exists in VLS, i.e., to assess if an early treatment may prevent disease progression and facilitate clearance of symptoms and/or signs. Methods: This retrospective, cohort study included VLS patients treated for the first time with a topical corticosteroid, namely with mometasone furoate 0.1% ointment, for 12 weeks (2016–2021). Scoring of subjective symptoms (global subjective score, GSS, and dyspareunia) and clinical features (global objective score [GOS] and sclerosis-scarring-atrophy) was performed at baseline (T0) and at the control visit (T1). We assessed if the achievement of clearance in GSS, GOS, sclerosis-scarring-atrophy, or dyspareunia depended on the time elapsed between VLS onset and treatment initiation. Results: Among the 168 patients (59.2 ± 13.2 years) included, the median time between VLS onset and first treatment was 14.0 months. At T1, 48.8% of patients achieved clearance of GSS, 28% of GOS and 11.9% of both GSS and GOS, 57.9% of dyspareunia, and 19.2% of sclerosis-scarring-atrophy. The logistic regression model showed that each 10-month increase in treatment initiation adversely affected the clearance of GSS while starting treatment within 6 months of disease onset was significantly associated with clearance of GOS and sclerosis-scarring-atrophy. Conclusion: Early treatment is crucial in determining a complete healing of VLS-related symptoms and signs, especially of tissue sclerosis-scarring-atrophy, which appear poorly responsive, or even unresponsive, after the earliest stages of the disease. Thus our findings provide evidence for a "window of opportunity" in VLS treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Efficacy of dupilumab in the treatment of severe vulvar pruritus associated with lichen sclerosus et atrophicus: a case report
- Author
-
Na Du, Qiuyu Mao, Jingyi Yang, Yiwen Zhang, Xinyan Lyu, Yueyue Li, Wei Min, and Jing Xu
- Subjects
lichen sclerosus et atrophicus ,pruritus ,biologicals ,dupilumab ,treatment ,Medicine (General) ,R5-920 - Abstract
Lichen sclerosus et atrophicus (LSA) is a chronic inflammatory skin lesion with an undefined cause. It is more commonly found in the genital area, particularly in adolescents, premenopausal women and postmenopausal women. LSA is difficult to treat and often recurs. The primary treatment for LSA involves the administration of potent topical corticosteroids. Dupilumab is increasingly being used for the treatment of itching in non-atopic dermatitis patients but there are few reports on its use for the treatment of LSA. Here, we present a case of LSA in a 61-year-old woman with extensive vulvar itching. Over four months of dupilumab therapy, significant therapeutic effects were observed, including vulvar skin thinning and pruritus relief without adverse reactions.
- Published
- 2024
- Full Text
- View/download PDF
50. An unusual presentation of childhood lichen planus successfully treated with 308‐nm excimer laser.
- Author
-
Mzoughi, Dorsaf, Rabhi, Faten, Slimane, Malek Ben, Mallek, Ines, Jaber, Kahena, and Dhaoui, Mohamed Raouf
- Subjects
- *
LICHEN sclerosus et atrophicus , *ORAL lichen planus , *CHILD patients , *LICHEN planus , *EXCIMER lasers , *SKIN cancer , *PTERYGIUM - Abstract
This article discusses a case of childhood lichen planus, a common inflammatory skin condition, in a 4-year-old patient. The patient presented with non-itchy unilateral lesions on the left elbow. After unsuccessful treatment with topical corticosteroids, the patient underwent 308-nm excimer laser therapy, which resulted in 100% clearance of the lesions without relapse for 2 years. The article highlights the effectiveness and safety of excimer laser therapy in treating childhood lichen planus, particularly in young patients with localized lesions. However, the high cost and limited access to the therapy may pose challenges in its widespread use. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.